Prostatis Group’s Global X US Preferred ETF PFFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-27,769
Closed -$138K 191
2023
Q2
$138K Buy
+27,769
New +$538K 0.06% 123
2022
Q2
Sell
-9,606
Closed -$226K 71
2022
Q1
$226K Sell
9,606
-7,161
-43% -$171K 0.18% 72
2021
Q4
$432K Sell
16,767
-2,492
-13% -$63.8K 0.26% 57
2021
Q3
$496K Sell
19,259
-2,245
-10% -$58.4K 0.3% 57
2021
Q2
$563K Buy
21,504
+5,090
+31% +$131K 0.38% 52
2021
Q1
$419K Sell
16,414
-5,105
-24% -$129K 0.33% 68
2020
Q4
$555K Buy
21,519
+5,009
+30% +$127K 0.46% 49
2020
Q3
$409K Buy
+16,510
New +$405K 0.39% 51

Other funds holding PFFD

Prostatis Group's PFFD Position: Q3 2023 in Review

Prostatis Group sold out of Global X US Preferred ETF (PFFD) in Q3 2023, closing a stake of 27,769 shares — an estimated $138K sold.

Prostatis Group first reported a position in PFFD in Q3 2020 and held it in 8 quarters. The position peaked at $563K in Q2 2021. 238 funds tracked by Wall St. Rank hold PFFD as of Q3 2023.

  • Prostatis Group reported no remaining Global X US Preferred ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 27,769 Global X US Preferred ETF shares in Q3 2023, an estimated $138K.
  • Prostatis Group first reported a position in Global X US Preferred ETF in Q3 2020 and held it in 8 quarters.
  • Prostatis Group's Global X US Preferred ETF position peaked at $563K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Global X US Preferred ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.